These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 25380665

  • 1. Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats.
    Sharma AN, Pise A, Sharma JN, Shukla P.
    Metab Brain Dis; 2015 Jun; 30(3):719-30. PubMed ID: 25380665
    [Abstract] [Full Text] [Related]

  • 2. Dipeptidyl-peptidase IV (DPP-IV) inhibitor delays tolerance to anxiolytic effect of ethanol and withdrawal-induced anxiety in rats.
    Sharma AN, Pise A, Sharma JN, Shukla P.
    Metab Brain Dis; 2015 Jun; 30(3):659-67. PubMed ID: 25129124
    [Abstract] [Full Text] [Related]

  • 3. Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats.
    Taksande BG, Kotagale NR, Patel MR, Shelkar GP, Ugale RR, Chopde CT.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):89-101. PubMed ID: 20394743
    [Abstract] [Full Text] [Related]

  • 4. Topiramate reduces basal anxiety and relieves ethanol withdrawal-induced anxious behaviors in male rats.
    Junqueira-Ayres DD, Asth L, Ayres AS, Lobão-Soares B, Soares-Rachetti VP, Gavioli EC.
    Exp Clin Psychopharmacol; 2017 Apr 10; 25(2):105-113. PubMed ID: 28287793
    [Abstract] [Full Text] [Related]

  • 5. Enkephalin analog, cyclo[N(ε),N(β)-carbonyl-D-Lys(2),Dap(5)] enkephalinamide (cUENK6), inhibits the ethanol withdrawal-induced anxiety-like behavior in rats.
    Gibula-Bruzda E, Marszalek-Grabska M, Witkowska E, Izdebski J, Kotlinska JH.
    Alcohol; 2015 May 10; 49(3):229-36. PubMed ID: 25716198
    [Abstract] [Full Text] [Related]

  • 6. Liraglutide Reduces Alcohol Consumption, Anxiety, Memory Impairment, and Synapse Loss in Alcohol Dependent Mice.
    Liu W, Wang Z, Wang W, Wang Z, Xing Y, Hölscher C.
    Neurochem Res; 2024 Apr 10; 49(4):1061-1075. PubMed ID: 38267691
    [Abstract] [Full Text] [Related]

  • 7. Neurobehavioral effects of liraglutide and sitagliptin in experimental models.
    Kamble M, Gupta R, Rehan HS, Gupta LK.
    Eur J Pharmacol; 2016 Mar 05; 774():64-70. PubMed ID: 26849938
    [Abstract] [Full Text] [Related]

  • 8. Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats.
    Wen D, Sun D, Zang G, Hao L, Liu X, Yu F, Ma C, Cong B.
    Neuroscience; 2014 Sep 26; 277():14-25. PubMed ID: 24993476
    [Abstract] [Full Text] [Related]

  • 9. Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats.
    Sharma AN, Chopde CT, Hirani K, Kokare DM, Ugale RR.
    Eur J Pharmacol; 2007 Jul 19; 567(3):211-22. PubMed ID: 17511983
    [Abstract] [Full Text] [Related]

  • 10. Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats.
    Zhang Z, Morse AC, Koob GF, Schulteis G.
    Alcohol Clin Exp Res; 2007 Nov 19; 31(11):1811-9. PubMed ID: 17877783
    [Abstract] [Full Text] [Related]

  • 11. Attenuation of ethanol abstinence-induced anxiety- and depressive-like behavior by the phosphodiesterase-4 inhibitor rolipram in rodents.
    Gong MF, Wen RT, Xu Y, Pan JC, Fei N, Zhou YM, Xu JP, Liang JH, Zhang HT.
    Psychopharmacology (Berl); 2017 Oct 19; 234(20):3143-3151. PubMed ID: 28748375
    [Abstract] [Full Text] [Related]

  • 12. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
    Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF.
    Alcohol Clin Exp Res; 2002 Oct 19; 26(10):1494-501. PubMed ID: 12394282
    [Abstract] [Full Text] [Related]

  • 13. The effect of glucagon like peptide-1 receptor agonist on behavioral despair and anxiety-like behavior in ovariectomized rats: Modulation of BDNF/CREB, Nrf2 and lipocalin 2.
    Sağlam C, Turan İ, Özaçmak HS.
    Behav Brain Res; 2022 Oct 28; 435():114053. PubMed ID: 35961539
    [Abstract] [Full Text] [Related]

  • 14. Modulation of ethanol withdrawal-induced anxiety-like behavior during later withdrawals by treatment of early withdrawals with benzodiazepine/gamma-aminobutyric acid ligands.
    Knapp DJ, Overstreet DH, Breese GR.
    Alcohol Clin Exp Res; 2005 Apr 28; 29(4):553-63. PubMed ID: 15834220
    [Abstract] [Full Text] [Related]

  • 15. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J, Pachuta A, Bochenski M, Silberring J.
    Peptides; 2009 Jun 28; 30(6):1165-72. PubMed ID: 19463751
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of acute ethanol administration on ethanol withdrawal-induced anxiety-like syndrome in rats: A biochemical study.
    Kumar J, Hapidin H, Get Bee YT, Ismail Z.
    Alcohol; 2016 Feb 28; 50():9-17. PubMed ID: 26626323
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The influence of various glutamate receptors antagonists on anxiety-like effect of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J, Bochenski M.
    Eur J Pharmacol; 2008 Nov 19; 598(1-3):57-63. PubMed ID: 18838071
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.